Idiopathic Nephrotic Syndrome Completed Phase 3 Trials for Mycophenolate mofetil (DB00688)

IndicationStatusPhase
DBCOND0033235 (Idiopathic Nephrotic Syndrome)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01092962Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in ChildrenTreatment